Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.182EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.218EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.218EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.12.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.12.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ER.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.640EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.640EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.177.61EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.47EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.251EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.251EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.256EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.256EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.64EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.221.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DP.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BL.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XJEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BR.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBF.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.29EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-11629.5South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used